nodes	percent_of_prediction	percent_of_DWPC	metapath
Halothane—ND1—Metformin—polycystic ovary syndrome	0.645	1	CbGbCtD
Halothane—KCNJ3—pituitary gland—polycystic ovary syndrome	0.00379	0.0294	CbGeAlD
Halothane—KCNJ3—adrenal gland—polycystic ovary syndrome	0.00339	0.0263	CbGeAlD
Halothane—GNG2—pituitary gland—polycystic ovary syndrome	0.00317	0.0245	CbGeAlD
Halothane—GNG2—adipose tissue—polycystic ovary syndrome	0.00315	0.0244	CbGeAlD
Halothane—KCNJ3—endocrine gland—polycystic ovary syndrome	0.00294	0.0228	CbGeAlD
Halothane—GNG2—adrenal gland—polycystic ovary syndrome	0.00283	0.0219	CbGeAlD
Halothane—KCNK2—adrenal cortex—polycystic ovary syndrome	0.00279	0.0216	CbGeAlD
Halothane—KCNK3—adrenal cortex—polycystic ovary syndrome	0.0027	0.0209	CbGeAlD
Halothane—GNG2—female gonad—polycystic ovary syndrome	0.00264	0.0204	CbGeAlD
Halothane—GNG2—vagina—polycystic ovary syndrome	0.00262	0.0203	CbGeAlD
Halothane—GNG2—endocrine gland—polycystic ovary syndrome	0.00245	0.019	CbGeAlD
Halothane—CYP2C9—urine—polycystic ovary syndrome	0.00239	0.0185	CbGeAlD
Halothane—CYP2E1—urine—polycystic ovary syndrome	0.00227	0.0175	CbGeAlD
Halothane—KCNK2—adipose tissue—polycystic ovary syndrome	0.00225	0.0174	CbGeAlD
Halothane—KCNK2—adrenal gland—polycystic ovary syndrome	0.00202	0.0156	CbGeAlD
Halothane—KCNK3—adrenal gland—polycystic ovary syndrome	0.00195	0.0151	CbGeAlD
Halothane—GLRB—pituitary gland—polycystic ovary syndrome	0.00189	0.0146	CbGeAlD
Halothane—GLRB—adipose tissue—polycystic ovary syndrome	0.00188	0.0146	CbGeAlD
Halothane—KCNK10—endocrine gland—polycystic ovary syndrome	0.00187	0.0145	CbGeAlD
Halothane—KCNK2—vagina—polycystic ovary syndrome	0.00187	0.0145	CbGeAlD
Halothane—CYP3A4—urine—polycystic ovary syndrome	0.00182	0.0141	CbGeAlD
Halothane—CYP2D6—urine—polycystic ovary syndrome	0.00179	0.0139	CbGeAlD
Halothane—KCNN4—endometrium—polycystic ovary syndrome	0.00178	0.0137	CbGeAlD
Halothane—GABRG3—pituitary gland—polycystic ovary syndrome	0.0017	0.0132	CbGeAlD
Halothane—KCNK3—endocrine gland—polycystic ovary syndrome	0.00169	0.0131	CbGeAlD
Halothane—GLRB—adrenal gland—polycystic ovary syndrome	0.00169	0.0131	CbGeAlD
Halothane—KCNN4—uterus—polycystic ovary syndrome	0.00164	0.0127	CbGeAlD
Halothane—KCNN4—adipose tissue—polycystic ovary syndrome	0.0016	0.0124	CbGeAlD
Halothane—GLRB—vagina—polycystic ovary syndrome	0.00156	0.0121	CbGeAlD
Halothane—ATP5D—adrenal cortex—polycystic ovary syndrome	0.00151	0.0117	CbGeAlD
Halothane—ATP2C1—adrenal cortex—polycystic ovary syndrome	0.00149	0.0115	CbGeAlD
Halothane—KCNN4—adrenal gland—polycystic ovary syndrome	0.00144	0.0111	CbGeAlD
Halothane—GRIN2A—adrenal gland—polycystic ovary syndrome	0.00141	0.0109	CbGeAlD
Halothane—ND1—adrenal gland—polycystic ovary syndrome	0.00135	0.0105	CbGeAlD
Halothane—ATP5D—endometrium—polycystic ovary syndrome	0.00135	0.0104	CbGeAlD
Halothane—KCNN4—vagina—polycystic ovary syndrome	0.00133	0.0103	CbGeAlD
Halothane—ATP2C1—endometrium—polycystic ovary syndrome	0.00133	0.0103	CbGeAlD
Halothane—GABRB1—pituitary gland—polycystic ovary syndrome	0.00131	0.0102	CbGeAlD
Halothane—GRIN2A—vagina—polycystic ovary syndrome	0.0013	0.0101	CbGeAlD
Halothane—GABRP—endometrium—polycystic ovary syndrome	0.0013	0.0101	CbGeAlD
Halothane—ND1—female gonad—polycystic ovary syndrome	0.00126	0.00974	CbGeAlD
Halothane—KCNMA1—uterus—polycystic ovary syndrome	0.00125	0.00969	CbGeAlD
Halothane—KCNN4—endocrine gland—polycystic ovary syndrome	0.00124	0.00964	CbGeAlD
Halothane—ATP5D—uterus—polycystic ovary syndrome	0.00124	0.0096	CbGeAlD
Halothane—ATP2C1—uterus—polycystic ovary syndrome	0.00122	0.00948	CbGeAlD
Halothane—KCNMA1—adipose tissue—polycystic ovary syndrome	0.00122	0.00948	CbGeAlD
Halothane—GRIN2A—endocrine gland—polycystic ovary syndrome	0.00122	0.00945	CbGeAlD
Halothane—ATP5D—pituitary gland—polycystic ovary syndrome	0.00122	0.00943	CbGeAlD
Halothane—ATP5D—adipose tissue—polycystic ovary syndrome	0.00121	0.00939	CbGeAlD
Halothane—ATP2C1—pituitary gland—polycystic ovary syndrome	0.0012	0.00931	CbGeAlD
Halothane—GABRP—uterus—polycystic ovary syndrome	0.0012	0.00929	CbGeAlD
Halothane—ATP2C1—adipose tissue—polycystic ovary syndrome	0.0012	0.00927	CbGeAlD
Halothane—GABRA4—pituitary gland—polycystic ovary syndrome	0.00119	0.00919	CbGeAlD
Halothane—GABRP—pituitary gland—polycystic ovary syndrome	0.00118	0.00912	CbGeAlD
Halothane—ND1—endocrine gland—polycystic ovary syndrome	0.00117	0.00906	CbGeAlD
Halothane—KCNMA1—adrenal gland—polycystic ovary syndrome	0.0011	0.0085	CbGeAlD
Halothane—GABRB1—vagina—polycystic ovary syndrome	0.00109	0.00843	CbGeAlD
Halothane—ATP5D—adrenal gland—polycystic ovary syndrome	0.00109	0.00842	CbGeAlD
Halothane—ATP2C1—adrenal gland—polycystic ovary syndrome	0.00107	0.00831	CbGeAlD
Halothane—CYP2A6—adipose tissue—polycystic ovary syndrome	0.00102	0.00792	CbGeAlD
Halothane—ATP5D—female gonad—polycystic ovary syndrome	0.00101	0.00785	CbGeAlD
Halothane—ATP5D—vagina—polycystic ovary syndrome	0.00101	0.00781	CbGeAlD
Halothane—ATP2C1—female gonad—polycystic ovary syndrome	0.001	0.00775	CbGeAlD
Halothane—ATP2C1—vagina—polycystic ovary syndrome	0.000995	0.00771	CbGeAlD
Halothane—GABRE—endometrium—polycystic ovary syndrome	0.000994	0.0077	CbGeAlD
Halothane—GABRG2—pituitary gland—polycystic ovary syndrome	0.000993	0.00769	CbGeAlD
Halothane—GABRP—vagina—polycystic ovary syndrome	0.000975	0.00755	CbGeAlD
Halothane—KCNMA1—endocrine gland—polycystic ovary syndrome	0.000952	0.00737	CbGeAlD
Halothane—GABRA3—endocrine gland—polycystic ovary syndrome	0.000943	0.0073	CbGeAlD
Halothane—ATP5D—endocrine gland—polycystic ovary syndrome	0.000943	0.0073	CbGeAlD
Halothane—ATP2C1—endocrine gland—polycystic ovary syndrome	0.000931	0.00721	CbGeAlD
Halothane—GABRA2—adipose tissue—polycystic ovary syndrome	0.000903	0.00699	CbGeAlD
Halothane—GABRE—pituitary gland—polycystic ovary syndrome	0.000899	0.00696	CbGeAlD
Halothane—GABRE—adipose tissue—polycystic ovary syndrome	0.000896	0.00694	CbGeAlD
Halothane—CYP2A6—vagina—polycystic ovary syndrome	0.00085	0.00658	CbGeAlD
Halothane—GABRA2—adrenal gland—polycystic ovary syndrome	0.00081	0.00627	CbGeAlD
Halothane—GABRE—adrenal gland—polycystic ovary syndrome	0.000803	0.00622	CbGeAlD
Halothane—GABRB3—pituitary gland—polycystic ovary syndrome	0.000762	0.0059	CbGeAlD
Halothane—GABRA2—vagina—polycystic ovary syndrome	0.000751	0.00581	CbGeAlD
Halothane—GABRE—female gonad—polycystic ovary syndrome	0.000749	0.0058	CbGeAlD
Halothane—GABRE—vagina—polycystic ovary syndrome	0.000745	0.00577	CbGeAlD
Halothane—ALB—adrenal gland—polycystic ovary syndrome	0.000732	0.00567	CbGeAlD
Halothane—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.00064	0.00495	CbGeAlD
Halothane—GABRB3—endocrine gland—polycystic ovary syndrome	0.00059	0.00457	CbGeAlD
Halothane—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000462	0.00358	CbGeAlD
Halothane—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000433	0.00336	CbGeAlD
Halothane—CYP2B6—vagina—polycystic ovary syndrome	0.000428	0.00331	CbGeAlD
Halothane—CYP2B6—endocrine gland—polycystic ovary syndrome	0.0004	0.0031	CbGeAlD
Halothane—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000396	0.00307	CbGeAlD
Halothane—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000376	0.00291	CbGeAlD
Halothane—CYP2D6—female gonad—polycystic ovary syndrome	0.00032	0.00248	CbGeAlD
Halothane—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000302	0.00234	CbGeAlD
Halothane—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000297	0.0023	CbGeAlD
Halothane—CYP2C9—Metabolism—LPCAT2—polycystic ovary syndrome	2.05e-05	9.09e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—SUOX—polycystic ovary syndrome	2.05e-05	9.09e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.04e-05	9.03e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	2.03e-05	8.98e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	2.02e-05	8.94e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—NRG1—polycystic ovary syndrome	2e-05	8.86e-05	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.99e-05	8.84e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	1.98e-05	8.78e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—TEAD2—polycystic ovary syndrome	1.98e-05	8.78e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PNPLA2—polycystic ovary syndrome	1.97e-05	8.74e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—HMMR—polycystic ovary syndrome	1.97e-05	8.73e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PNPLA2—polycystic ovary syndrome	1.93e-05	8.56e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	1.92e-05	8.53e-05	CbGpPWpGaD
Halothane—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	1.92e-05	8.5e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—ISYNA1—polycystic ovary syndrome	1.91e-05	8.45e-05	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	1.91e-05	8.45e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.91e-05	8.44e-05	CbGpPWpGaD
Halothane—CYP2C9—Biological oxidations—POMC—polycystic ovary syndrome	1.9e-05	8.43e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—PLAT—polycystic ovary syndrome	1.9e-05	8.4e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—HSD3B1—polycystic ovary syndrome	1.88e-05	8.33e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.88e-05	8.31e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—SRD5A1—polycystic ovary syndrome	1.87e-05	8.29e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	1.86e-05	8.26e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—SRD5A1—polycystic ovary syndrome	1.83e-05	8.12e-05	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	1.83e-05	8.1e-05	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	1.83e-05	8.1e-05	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—IL6—polycystic ovary syndrome	1.81e-05	8.02e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—STAR—polycystic ovary syndrome	1.78e-05	7.91e-05	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	1.77e-05	7.82e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—STAR—polycystic ovary syndrome	1.75e-05	7.74e-05	CbGpPWpGaD
Halothane—GNG2—Metabolism—PPARG—polycystic ovary syndrome	1.75e-05	7.74e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.74e-05	7.71e-05	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	1.74e-05	7.7e-05	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	1.73e-05	7.65e-05	CbGpPWpGaD
Halothane—GNG2—Metabolism—POMC—polycystic ovary syndrome	1.72e-05	7.63e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—LHB—polycystic ovary syndrome	1.71e-05	7.6e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IRS2—polycystic ovary syndrome	1.71e-05	7.59e-05	CbGpPWpGaD
Halothane—GNG2—Metabolism—INS—polycystic ovary syndrome	1.71e-05	7.59e-05	CbGpPWpGaD
Halothane—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.68e-05	7.45e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—LEP—polycystic ovary syndrome	1.68e-05	7.43e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—HSD3B2—polycystic ovary syndrome	1.68e-05	7.43e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	1.66e-05	7.36e-05	CbGpPWpGaD
Halothane—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.66e-05	7.35e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	1.65e-05	7.32e-05	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.64e-05	7.27e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	1.64e-05	7.25e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	1.64e-05	7.25e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—AKR1C1—polycystic ovary syndrome	1.62e-05	7.19e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	1.62e-05	7.19e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	1.62e-05	7.19e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—HMMR—polycystic ovary syndrome	1.59e-05	7.05e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	1.57e-05	6.98e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	1.56e-05	6.91e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	1.56e-05	6.9e-05	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.55e-05	6.85e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	1.54e-05	6.8e-05	CbGpPWpGaD
Halothane—RHO—Disease—IL6—polycystic ovary syndrome	1.53e-05	6.77e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—HSD3B1—polycystic ovary syndrome	1.52e-05	6.72e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—STAR—polycystic ovary syndrome	1.5e-05	6.65e-05	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.5e-05	6.65e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.5e-05	6.62e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—SULT2A1—polycystic ovary syndrome	1.49e-05	6.62e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	1.49e-05	6.58e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.48e-05	6.58e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.48e-05	6.56e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—GNAS—polycystic ovary syndrome	1.46e-05	6.45e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—RRM2—polycystic ovary syndrome	1.45e-05	6.41e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—POMC—polycystic ovary syndrome	1.44e-05	6.38e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—INS—polycystic ovary syndrome	1.43e-05	6.34e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—YAP1—polycystic ovary syndrome	1.39e-05	6.18e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.38e-05	6.14e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.38e-05	6.13e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—LHB—polycystic ovary syndrome	1.38e-05	6.13e-05	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—IL6—polycystic ovary syndrome	1.38e-05	6.11e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	1.37e-05	6.08e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	1.36e-05	6.02e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	1.35e-05	6e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.35e-05	6e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.35e-05	6e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—HSD3B2—polycystic ovary syndrome	1.35e-05	5.99e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—NAMPT—polycystic ovary syndrome	1.34e-05	5.94e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—HMMR—polycystic ovary syndrome	1.34e-05	5.93e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	1.32e-05	5.87e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CYP11A1—polycystic ovary syndrome	1.32e-05	5.86e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.32e-05	5.83e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—AKR1C1—polycystic ovary syndrome	1.31e-05	5.8e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	1.3e-05	5.76e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	1.29e-05	5.71e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	1.28e-05	5.68e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	1.28e-05	5.66e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.26e-05	5.59e-05	CbGpPWpGaD
Halothane—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.26e-05	5.58e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.26e-05	5.58e-05	CbGpPWpGaD
Halothane—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.25e-05	5.56e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—AKR1C3—polycystic ovary syndrome	1.25e-05	5.54e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	1.24e-05	5.49e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CYP17A1—polycystic ovary syndrome	1.23e-05	5.45e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	1.23e-05	5.45e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	1.22e-05	5.38e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—SULT2A1—polycystic ovary syndrome	1.21e-05	5.34e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.2e-05	5.3e-05	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	1.19e-05	5.29e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	1.18e-05	5.23e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	1.17e-05	5.17e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—LHB—polycystic ovary syndrome	1.16e-05	5.16e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	1.14e-05	5.07e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	1.14e-05	5.04e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	1.13e-05	4.99e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	1.11e-05	4.9e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	1.1e-05	4.88e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	1.1e-05	4.88e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	1.1e-05	4.86e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	1.08e-05	4.79e-05	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—IL6—polycystic ovary syndrome	1.07e-05	4.74e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.07e-05	4.74e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.07e-05	4.74e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	1.07e-05	4.73e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—TH—polycystic ovary syndrome	1.06e-05	4.72e-05	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.06e-05	4.69e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	1.06e-05	4.69e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	1.05e-05	4.67e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	1.05e-05	4.63e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	1.05e-05	4.63e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—SLC2A4—polycystic ovary syndrome	1.04e-05	4.59e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.03e-05	4.58e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	1.01e-05	4.5e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	1.01e-05	4.47e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	9.92e-06	4.4e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	9.87e-06	4.38e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—RRM2—polycystic ovary syndrome	9.83e-06	4.35e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	9.79e-06	4.34e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CYP19A1—polycystic ovary syndrome	9.73e-06	4.31e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	9.72e-06	4.31e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	9.61e-06	4.26e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	9.53e-06	4.22e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—YAP1—polycystic ovary syndrome	9.47e-06	4.2e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—IGF1—polycystic ovary syndrome	9.43e-06	4.18e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—AKT2—polycystic ovary syndrome	9.42e-06	4.17e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	9.4e-06	4.16e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	9.32e-06	4.13e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	9.1e-06	4.03e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—NAMPT—polycystic ovary syndrome	9.1e-06	4.03e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.05e-06	4.01e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.05e-06	4.01e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	9.02e-06	4e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	8.99e-06	3.98e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	8.96e-06	3.97e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	8.95e-06	3.97e-05	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.92e-06	3.95e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	8.69e-06	3.85e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—TH—polycystic ovary syndrome	8.59e-06	3.81e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	8.5e-06	3.77e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	8.49e-06	3.76e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—TH—polycystic ovary syndrome	8.41e-06	3.73e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	8.38e-06	3.71e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	8.35e-06	3.7e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	8.35e-06	3.7e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	8.3e-06	3.68e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	8.28e-06	3.67e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	8.18e-06	3.63e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	8.11e-06	3.59e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.11e-06	3.59e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	8.04e-06	3.56e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	7.85e-06	3.48e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	7.85e-06	3.48e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	7.82e-06	3.47e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	7.75e-06	3.44e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	7.69e-06	3.41e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	7.51e-06	3.33e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	7.45e-06	3.3e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	7.42e-06	3.29e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.4e-06	3.28e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	7.36e-06	3.26e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	7.31e-06	3.24e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.3e-06	3.24e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—TH—polycystic ovary syndrome	7.23e-06	3.2e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.23e-06	3.2e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	7.03e-06	3.12e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	7.01e-06	3.11e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	7.01e-06	3.1e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	6.95e-06	3.08e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	6.9e-06	3.06e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	6.89e-06	3.05e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	6.87e-06	3.04e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	6.84e-06	3.03e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	6.68e-06	2.96e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	6.61e-06	2.93e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	6.54e-06	2.9e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	6.33e-06	2.81e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.29e-06	2.79e-05	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IL6—polycystic ovary syndrome	6.26e-06	2.77e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	6.2e-06	2.75e-05	CbGpPWpGaD
Halothane—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	6.16e-06	2.73e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.14e-06	2.72e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—TH—polycystic ovary syndrome	5.97e-06	2.64e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	5.95e-06	2.64e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	5.93e-06	2.63e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—TH—polycystic ovary syndrome	5.92e-06	2.62e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	5.9e-06	2.62e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—GNAS—polycystic ovary syndrome	5.9e-06	2.61e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	5.85e-06	2.59e-05	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—INS—polycystic ovary syndrome	5.82e-06	2.58e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	5.81e-06	2.57e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	5.78e-06	2.56e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	5.76e-06	2.55e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—NCOR1—polycystic ovary syndrome	5.62e-06	2.49e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.48e-06	2.43e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	5.46e-06	2.42e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	5.41e-06	2.4e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	5.33e-06	2.36e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.3e-06	2.35e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.11e-06	2.27e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—MTHFR—polycystic ovary syndrome	4.97e-06	2.2e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.91e-06	2.18e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	4.87e-06	2.16e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.85e-06	2.15e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	4.83e-06	2.14e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	4.79e-06	2.12e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	4.72e-06	2.09e-05	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—INS—polycystic ovary syndrome	4.69e-06	2.08e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	4.69e-06	2.08e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	4.64e-06	2.06e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	4.62e-06	2.05e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	4.6e-06	2.04e-05	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—INS—polycystic ovary syndrome	4.6e-06	2.04e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.58e-06	2.03e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.51e-06	2e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	4.4e-06	1.95e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	4.36e-06	1.93e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	4.1e-06	1.82e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	4.07e-06	1.8e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—PPARG—polycystic ovary syndrome	4.03e-06	1.79e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—POMC—polycystic ovary syndrome	3.97e-06	1.76e-05	CbGpPWpGaD
Halothane—ALB—Metabolism—INS—polycystic ovary syndrome	3.95e-06	1.75e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.9e-06	1.73e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.8e-06	1.68e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.57e-06	1.58e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	3.33e-06	1.47e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	3.3e-06	1.46e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	3.28e-06	1.45e-05	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.26e-06	1.45e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	3.25e-06	1.44e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—INS—polycystic ovary syndrome	3.23e-06	1.43e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.19e-06	1.41e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.03e-06	1.34e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.88e-06	1.27e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.68e-06	1.19e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.17e-06	9.64e-06	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.14e-06	9.5e-06	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.13e-06	9.45e-06	CbGpPWpGaD
